HX575: established biosimilarity in the treatment of renal anemia and 10 years of clinical experience

HX575: established biosimilarity in the treatment of renal anemia and 10 years of clinical experience

Frank Dellanna,1 David Goldsmith,2 Andriy Krendyukov,3 Andreas Seidl,4 Nadja Höbel,5 Christian Combe6,7 1MVZ Davita Rhein-Ruhr, Düsseldorf, Germany; 2Division of Nephrology, Guy’s and St Thomas’ Hospitals, London, UK; 3Hematology/Nephrology, Hexal AG, Holzkirch...

Full description

Bibliographic Details
Main Authors: Dellanna F, Goldsmith D, Krendyukov A, Seidl A, Höbel N, Combe C
Format: Article
Language:English
Published: Dove Medical Press 2017-12-01
Series:Drug Design, Development and Therapy
Subjects:
Binocrit
HX575
anemia
chronic kidney disease
biosimilars
Online Access:https://www.dovepress.com/hx575-established-biosimilarity-in-the-treatment-of-renal-anemia-and-1-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/hx575-established-biosimilarity-in-the-treatment-of-renal-anemia-and-1-peer-reviewed-article-DDDT

Similar Items